A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy

NCT02623452 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Change in clinical strategy

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company